BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 30949321)

  • 1. Gene expression profile analysis of colon cancer grade II into grade III transition by using system biology.
    Rostami-Nejad M; Rezaei Tavirani S; Mansouri V; Jahani-Sherafat S; Moravvej Farshi H
    Gastroenterol Hepatol Bed Bench; 2019; 12(1):60-66. PubMed ID: 30949321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Network analysis of grade II into grade III transition in rectum cancer patients.
    Rostami-Nejad M; Mansouri V; Mahmoud Robati R; Mohaghegh Shalmani H; Mahmoudi Lamouki R; Rezaei Tavirani M
    Gastroenterol Hepatol Bed Bench; 2018; 11(Suppl 1):S118-S123. PubMed ID: 30774817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic analysis of acute appendicitis by using system biology approach.
    Zojaji H; Rezaei Tavirani M; Mansouri V; Seyed Salehi A; Mahmoud Robati R; Lak E
    Gastroenterol Hepatol Bed Bench; 2018; 11(Suppl 1):S92-S97. PubMed ID: 30774813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SRC and TP53 play critical role in low-grade dysplasia colorectal mucosa transformation into cancer.
    Asadzadeh-Aghdaei H; Zamanian Azodi M; Vafaee R; Moravvej Farshi H; Naderi N
    Gastroenterol Hepatol Bed Bench; 2018; 11(Suppl 1):S104-S110. PubMed ID: 30774815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Network analysis of liver cancer: a system biology approach.
    Arjmand B; Jahani Sherafat S; Rezaei Tavirani M; Hamzeloo Moghadam M; Abbasi MA
    Gastroenterol Hepatol Bed Bench; 2023; 16(3):319-325. PubMed ID: 37767318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting colon cancer via antimicrobial RT2 peptide: a system biology study.
    Hosseinpour Z; Zamanian Azodi M; Jahani Sherafat S; Rezaei Tavirani M
    Gastroenterol Hepatol Bed Bench; 2023; 16(4):415-420. PubMed ID: 38313359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common and differential genetically pathways between ulcerative colitis and colon adenocarcinoma.
    Akbari S; Hosseini M; Rezaei-Tavirani M; Rezaei-Tavirani M; Salehi SH; Alemrajabi M; Vaseghi-Maghvan P; Jahani-Sherafat S
    Gastroenterol Hepatol Bed Bench; 2017; 10(Suppl1):S93-S101. PubMed ID: 29511478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Faecal retention: a common cause in functional bowel disorders, appendicitis and haemorrhoids--with medical and surgical therapy.
    Raahave D
    Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer.
    Dalerba P; Sahoo D; Paik S; Guo X; Yothers G; Song N; Wilcox-Fogel N; Forgó E; Rajendran PS; Miranda SP; Hisamori S; Hutchison J; Kalisky T; Qian D; Wolmark N; Fisher GA; van de Rijn M; Clarke MF
    N Engl J Med; 2016 Jan; 374(3):211-22. PubMed ID: 26789870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of TP53 mutational status and gender with survival after adjuvant treatment for stage III colon cancer: results of CALGB 89803.
    Warren RS; Atreya CE; Niedzwiecki D; Weinberg VK; Donner DB; Mayer RJ; Goldberg RM; Compton CC; Zuraek MB; Ye C; Saltz LB; Bertagnolli MM
    Clin Cancer Res; 2013 Oct; 19(20):5777-87. PubMed ID: 23983256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin dysregulation plays a critical role in colon inflammation: a bioinformatics approach.
    Naderi N; Zamanian Azodi M; Daskar Abkenar E; Shahidi Dadras M; Talaei R
    Gastroenterol Hepatol Bed Bench; 2018; 11(Suppl 1):S85-S91. PubMed ID: 30774812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic relevance of Src activation in stage II-III colon cancer.
    Martínez-Pérez J; Lopez-Calderero I; Saez C; Benavent M; Limon ML; Gonzalez-Exposito R; Soldevilla B; Riesco-Martínez MC; Salamanca J; Carnero A; Garcia-Carbonero R
    Hum Pathol; 2017 Sep; 67():119-125. PubMed ID: 28601656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Potential molecular mechanism of Banxia Xiexin Decoction in treatment of colon cancer based on network pharmacology and molecular docking technology].
    Luo YT; Lin LF; Liu YL; Shi GL; Wu YQ; Yang AH; Li H
    Zhongguo Zhong Yao Za Zhi; 2020 Dec; 45(23):5753-5761. PubMed ID: 33496116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TP53 Mutational Status and Prediction of Benefit from Adjuvant 5-Fluorouracil in Stage III Colon Cancer Patients.
    Kandioler D; Mittlböck M; Kappel S; Puhalla H; Herbst F; Langner C; Wolf B; Tschmelitsch J; Schippinger W; Steger G; Hofbauer F; Samonigg H; Gnant M; Teleky B; Kührer I;
    EBioMedicine; 2015 Aug; 2(8):825-30. PubMed ID: 26425688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Network pharmacology-based study to explore the mechanism of the Yiqi Gubiao pill in lung cancer treatment.
    Li Z; Xu D; Jing J; Li F
    Oncol Lett; 2021 Apr; 21(4):321. PubMed ID: 33692853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GAPDH and PUM1: Optimal Housekeeping Genes for Quantitative Polymerase Chain Reaction-Based Analysis of Cancer Stem Cells and Epithelial-Mesenchymal Transition Gene Expression in Rectal Tumors.
    Vermani L; Kumar R; Senthil Kumar N
    Cureus; 2020 Dec; 12(12):e12020. PubMed ID: 33457124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Underlying Mechanism of Insulin Resistance: A Bioinformatics Analysis Based on Validated Related-Genes from Public Disease Databases.
    Gao P; Hu Y; Wang J; Ni Y; Zhu Z; Wang H; Yang J; Huang L; Fang L
    Med Sci Monit; 2020 Jul; 26():e924334. PubMed ID: 32651353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinformatic analysis of potential candidates for therapy of inflammatory bowel disease.
    Li XL; Zhou CY; Sun Y; Su ZY; Wang X; N Jia E; Zhang Q; Jiang XF; Qi WQ; Xu Y
    Eur Rev Med Pharmacol Sci; 2015 Nov; 19(22):4275-84. PubMed ID: 26636514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pro-apoptotic protein Prostate Apoptosis Response Protein-4 (Par-4) can be activated in colon cancer cells by treatment with Src inhibitor and 5-FU.
    Kline CL; Irby RB
    Apoptosis; 2011 Dec; 16(12):1285-94. PubMed ID: 21910008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of CDX2 protein expression improves its clinical utility as a prognostic biomarker in stage II and III colon cancer.
    den Uil SH; de Wit M; Slebos RJC; Delis-van Diemen PM; Sanders J; Piersma SR; Pham TV; Coupé VMH; Bril H; Stockmann HBAC; Jimenez CR; Meijer GA; Fijneman RJA
    Eur J Cancer; 2021 Feb; 144():91-100. PubMed ID: 33341450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.